In the last trading session, 1.31 million Allarity Therapeutics Inc (NASDAQ:ALLR) shares changed hands as the company’s beta touched -0.18. With the company’s per share price at $0.80 changed hands at $0.01 or 0.59% during last session, the market valuation stood at $13.54M. ALLR’s last price was a discount, traded about -21650.0% off its 52-week high of $174.00. The share price had its 52-week low at $0.68, which suggests the last value was 15.0% up since then. When we look at Allarity Therapeutics Inc’s average trading volume, we note the 10-day average is 1.87 million shares, with the 3-month average coming to 2.75 million.
Analysts gave the Allarity Therapeutics Inc (ALLR) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended ALLR as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight.
Allarity Therapeutics Inc (NASDAQ:ALLR) trade information
Instantly ALLR was in green as seen at the end of in last trading. With action -15.06%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -31.98%, with the 5-day performance at -15.06% in the red. However, in the 30-day time frame, Allarity Therapeutics Inc (NASDAQ:ALLR) is -24.92% down. Looking at the short shares, we see there were 0.48 million shares sold at short interest cover period of 0.2 days.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 84.72%.
ALLR Dividends
Allarity Therapeutics Inc is expected to release its next quarterly earnings report on 2024-Nov-13.
Allarity Therapeutics Inc (NASDAQ:ALLR)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 16.80% of Allarity Therapeutics Inc shares while 2.36% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 2.83%.
Among Mutual Funds, the top two as of Feb 28, 2025 were Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund . With 7.11 shares estimated at $5661.0 under it, the former controlled 0.04% of total outstanding shares. On the other hand, Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund held about 0.02% of the shares, roughly 3.3 shares worth around $2622.0.
